S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer

NCT00005975 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

288

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer
Hot Flashes

Interventions

DRUG: Megestrol Acetate 20mg/day
DRUG: Megestrol Acetate 40 mg/day
DRUG: Megestrol Acetate Placebo 20 mg/day
DRUG: Megestrol Acetate Placebo 40 mg/day

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]